Christine M. K.
- Country
- Germany
- Department
- Gießen Zentrum für Kinderheilkunde und Jugendmedizin Pädiatrische Hämatologie,Onkologie&Immundefekte
Research Overview
- International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
- Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia
Data & Insights
Has run more than one trial at 236 of 329 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in treating various forms of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) in pediatric patients. Their research encompasses both standard and high-risk cases, including specific focus on Philadelphia chromosome-positive ALL and KMT2A-rearranged infant ALL.
- Leukemia Treatment Innovations
- Stem Cell Transplantation
- Lymphoma Management
Solid Tumors
The investigator has extensive experience in treating pediatric solid tumors, particularly medulloblastoma, Ewing sarcoma, and neuroblastoma. Their work includes research on atypical teratoid/rhabdoid tumors (ATRT) and various brain tumor subtypes.
- Brain Tumor Protocols
- Sarcoma Treatments
- Risk-Adapted Therapies
Immunotherapy Applications
Their research includes innovative applications of immunotherapy agents such as pembrolizumab and blinatumomab in pediatric cancers. They also study rituximab-based treatments for B-cell lymphomas and graft-versus-host disease management.
- Novel Immunotherapy Protocols
- Targeted Therapies
- Post-Transplant Care
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.